Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist. - Tagat JR; Steensma RW; McCombie SW; Nazareno DV; Lin SI; Neustadt BR; Cox K; Xu S; Wojcik L; Murray MG; Vantuno N; Baroudy BM; et al. (Journal of medicinal chemistry, 2001)